A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection-Reference-Cited by-全球学者库

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection

Published:2021-08 Issue:8 Volume:17 Page:
ISSN:1744-4292
Container-title:Molecular Systems Biology
language:en
Short-container-title:Mol Syst Biol

Author:

Chen Fangyuan¹²^ORCID,Shi Qingya¹²^ORCID,Pei Fen¹³^ORCID,Vogt Andreas¹³^ORCID,Porritt Rebecca A⁴⁵,Garcia Gustavo⁶⁷,Gomez Angela C⁴,Cheng Mary Hongying¹,Schurdak Mark E¹³,Liu Bing¹^ORCID,Chan Stephen Y⁸⁹,Arumugaswami Vaithilingaraja⁶⁷,Stern Andrew M¹³^ORCID,Taylor D Lansing¹³,Arditi Moshe⁴⁵^ORCID,Bahar Ivet¹³^ORCID

Affiliation:

1. Department of Computational and Systems Biology School of Medicine University of Pittsburgh Pittsburgh PA USA

2. School of Medicine Tsinghua University Beijing China

3. University of Pittsburgh Drug Discovery Institute Pittsburgh PA USA

4. Department of Pediatrics Division of Pediatric Infectious Diseases and Immunology Cedars‐Sinai Medical Center Los Angeles CA USA

5. Biomedical Sciences, Infectious and Immunologic Diseases Research Center Cedars‐Sinai Medical Center Los Angeles CA USA

6. Department of Molecular and Medical Pharmacology David Geffen School of Medicine University of California Los Angeles CA USA

7. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research University of California Los Angeles CA USA

8. Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute University of Pittsburgh Medical Center Pittsburgh PA USA

9. Division of Cardiology Department of Medicine University of Pittsburgh Medical Center Pittsburgh PA USA

Funder

American Heart Association

American Lung Association

National Institutes of Health

Publisher

EMBO

Subject

Applied Mathematics,Computational Theory and Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Information Systems

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/msb.202110239

Reference127 articles.

1. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)

2. In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

3. Gene Ontology: tool for the unification of biology

4. The Novel Therapeutic Effect of Phosphoinositide 3-Kinase-γ Inhibitor AS605240 in Autoimmune Diabetes

5. The role of anticholinergics in chronic obstructive pulmonary disease;Barnes PJ;Am J Med,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome;Antiviral Research;2024-01

2. Rottlerin impairs early and late steps of Toxoplasma gondii infection in human trophoblast cells and villous explants;Chemico-Biological Interactions;2023-10

3. ARF6 is a host factor for SARS-CoV-2 infection in vitro;Journal of General Virology;2023-06-21

4. Rottlerin-Liposome Inhibits the Endocytosis of Feline Coronavirus Infection;Veterinary Sciences;2023-05-30

5. Application of perturbation gene expression profiles in drug discovery—From mechanism of action to quantitative modelling;Frontiers in Systems Biology;2023-02-09